PARP inhibitor niraparib as a radiosensitizer promotes antitumor immunity of radiotherapy in EGFR-mutated non-small cell lung cancerN. Zhang, Conghua Xie, Zihang Zeng et al.|Clinical & Translational Oncology|2021Cited by 32